贵州三力：悦欣医药减持计划已到期，累计减持公司股份约81万股

Group 1 - Guizhou Sanli announced that as of October 2, 2025, Yueshin Pharmaceutical completed its share reduction plan, selling approximately 810,000 shares, which accounts for 0.1976% of the company's total share capital [1] - The company's revenue composition for the year 2024 indicates that the pharmaceutical manufacturing sector contributes 99.97% to its total revenue, while other businesses account for only 0.03% [1] Group 2 - As of the latest report, Guizhou Sanli has a market capitalization of 5.1 billion yuan [2]